MARYLAND INDUSTRIAL PARTNERSHIPS

MIPS Project Detail:

Rexahn Corporation

Ligand screening for novel anticancer therapeutics

Project #

3501

 | 

Round 

35

 | 

Feb 2005

Back to Projects Home

Company

Rexahn Corporation

Rockville

Montgomery

 County
, Maryland
  |  
Founded: 

2001

  |  

Company Description: 

Rexahn Pharmaceuticals Inc. is a publicly traded clinical stage pharmaceutical company dedicated to commercializing first-in-class and best-in-class therapeutics for cancer and central nervous system (CNS) disorders. Rexahn currently has three drug candidates in Phase II clinical trials, Archexin®, Serdaxin®, and Zoraxel™—all potential best-in-class therapeutics. Rexahn also operates key R&D programs of nanomedicines, 3D-GOLD and TIMES drug discovery platforms.

MIPS Project

Round 

35

 - 

Feb 2005

Ligand screening for novel anticancer therapeutics

Project #

3501

 | 

MIPS Round 

35

 | 

Starting Date: 

Feb 2005

-

Results: 

Principal Investigator:

John

 

Orban

Project Manager: 

Chang

 

Ahn

Chairman/Chief Executive Officer

Technologies:

Biotechnology / Genetic Engineering